Literature DB >> 9622200

Effects of central leptin administration on blood pressure in normotensive rats.

R M Casto1, J M VanNess, J M Overton.   

Abstract

We tested the hypothesis that intracerebroventricular (i.c.v.) administration of leptin would increase mean arterial pressure (MAP) in ad libitum (AL) fed and food deprived (FD) normotensive rats. Male Sprague-Dawley rats were chronically instrumented with a guide cannula directed at the lateral ventricle and a carotid arterial catheter. Following recovery from surgery, the MAP and heart rate (HR) response to i.c.v. administration of vehicle (5 microl saline over 1 min) or leptin (0.3 microg or 3.0 microg in 5 microl saline) were determined in conscious, unrestrained AL fed (n=7-10) and 48-h FD (n=5-10) rats. Food deprivation significantly reduced MAP (AL=116+/-3; FD=104+/-3 mmHg; P < 0.01) without altering HR. In AL rats, high dose leptin (3.0 microg, i.c.v.) produced a significant increase in MAP when maximal responses were evaluated (9+/-2 mmHg; P < 0.05), but did not significantly alter MAP and HR over time during the 90 min measurement period. In FD rats, low dose leptin (0.3 microg, i.c.v.) produced significant elevations in MAP (7+/-3 mmHg) after a latency of 60 min, while high dose leptin (3.0 microg, i.c.v.) produced an increase in MAP within the first 10 min (10+/-3 mmHg) followed by an additional increase 1 h after injection (6+/-2 mmHg). Leptin administration also produced delayed increases in HR in FD rats (0.3 microg, 34+/-5 b.p.m.; 3.0 microg, 57+/-10 b.p.m). These results indicate that leptin may modulate cardiovascular function through central mechanisms and may do so to a greater extent in food deprived animals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9622200     DOI: 10.1016/s0304-3940(98)00223-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

Review 1.  Selective leptin resistance revisited.

Authors:  Allyn L Mark
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-24       Impact factor: 3.619

2.  Pathophysiological role of leptin in obesity-related hypertension.

Authors:  M Aizawa-Abe; Y Ogawa; H Masuzaki; K Ebihara; N Satoh; H Iwai; N Matsuoka; T Hayashi; K Hosoda; G Inoue; Y Yoshimasa; K Nakao
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

3.  Regional haemodynamic effects of recombinant murine or human leptin in conscious rats.

Authors:  S M Gardiner; P A Kemp; J E March; T Bennett
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

4.  Systemic leptin dose-dependently increases STAT3 phosphorylation within hypothalamic and hindbrain nuclei.

Authors:  James W Maniscalco; Linda Rinaman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

Review 5.  Leptin: sympathetic and cardiovascular effects.

Authors:  Robert J Richards; Anthony Blalock; Jie Liao; Efrain Reisin
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

Review 6.  Adipose tissue as an endocrine organ: role of leptin and adiponectin in the pathogenesis of cardiovascular diseases.

Authors:  A Fortuño; A Rodríguez; J Gómez-Ambrosi; G Frühbeck; J Díez
Journal:  J Physiol Biochem       Date:  2003-03       Impact factor: 4.158

7.  Involvement of hypothalamic AMP-activated protein kinase in leptin-induced sympathetic nerve activation.

Authors:  Mamoru Tanida; Naoki Yamamoto; Toshishige Shibamoto; Kamal Rahmouni
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

Review 8.  Differential Role of Leptin and Adiponectin in Cardiovascular System.

Authors:  C M Ghantous; Z Azrak; S Hanache; W Abou-Kheir; A Zeidan
Journal:  Int J Endocrinol       Date:  2015-05-03       Impact factor: 3.257

9.  Leptin into the rostral ventral lateral medulla (RVLM) augments renal sympathetic nerve activity and blood pressure.

Authors:  Maria J Barnes; David H McDougal
Journal:  Front Neurosci       Date:  2014-08-08       Impact factor: 4.677

10.  cAMP/PKA Agonist Restores the Fasting-Induced Down-Regulation of nNOS Expression in the Paraventricular Nucleus.

Authors:  Sang Bae Yoo; Seoul Lee; Joo Young Lee; Bom-Taeck Kim; Jong-Ho Lee; Jeong Won Jahng
Journal:  Korean J Physiol Pharmacol       Date:  2012-10-18       Impact factor: 2.016

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.